Master Classes

Browse All Trainings

Sexual Offending: Axis I Comorbidity and Psychopharmacology

Or log in to access your purchased courses

CE Credits: 4 Credits
Length: 4 Hours
Level: Introductory
CE Eligibility: APA, ASWB, ANCC, NBCC, NAADAC, CPA
Training Style: Video
Track: General
Intended Audience: Mental Health, Correctional, and Legal Professionals

Training Description

Sexual offenders frequently have comorbid Axis I psychiatric disorders that may be managed using pharmaceuticals. The identification and effective treatment of these conditions can significantly affect the course of sexual offender treatment and diminish recidivism risk. This ATSA Master Class will summarize the nature of psychiatric diagnoses in this population utilizing DSM-5 definitions and criteria. A review and rationale will be presented for incorporating specific “traditional” psychotropic medications as well as testosterone lowering medications into comprehensive treatment programs for sexual offenders.

Trainer Biography

Martin P. Kafka, MD is a Distinguished Life Fellow of the American Psychiatric Association and serves as Clinical Associate Professor of Psychiatry at Harvard Medical School as well as Senior Clinical Associate at McLean Hospital in Massachusetts. He was selected as a member of the Sexual and Gender Disorders Working Group (Paraphilias Sub-Working Group) of the American Psychiatric Association for the formulation of the Diagnostic and Statistical Manual, 5th Edition. In 2010, Dr. Kafka was awarded the Carnes Award for achievement by the Society for Sexual Health. He has published over 30 peer-reviewed publications.

Learning Objectives

This training is designed to help you:

  1. Distinguish dimensional from categorical approaches to psychiatric diagnosis in sex offenders
  2. Explore how brain development, androgen hormones, and neuropsychiatric disorders interact to contribute to sexual offending
  3. Develop refined assessment skills to better identify subtle manifestations of psychiatric comorbidities associated with sexual offending
  4. Assess the role for pharmacological treatments with sexual offenders

1 Sponsorship: The Global Institute of Forensic Research, LLC is approved by the American Psychological Association, National Board of Certified Counselors, National Association of Alcohol and Drug Abuse Counselors, and Canadian Psychological Association to sponsor continuing education trainings. The American Nurses Credentialing Center accepts Continuing Education Credit sponsored by the American Psychological Association. Th­e Global Institute of Forensic Research, LLC (provider #1371) is also approved as a provider for social work continuing education by the Association of Social Work Board(ASWB) www.aswb.org, through the Approved Continuing Education (ACE) program. ASWB Approval Period: June 8, 2016 - June 8, 2019. Social workers should contact their regulatory board to determine course approval. ­The Global Institute of Forensic Research, LLC maintains responsibility for this program and its contents.
2 Refund/Cancellation Policy: If you wish to request a refund on account of technical difficulties, please contact services@gifrinc.com.
3 Commercial Supports: The Global Institute of Forensic Research, LLC reports no conflicts of interest in the development and sponsorship of this training. The Global Institute of Forensic Research, LLC receives no commercial support for its Continuing Education programs or from its presenters.